Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 19INDUSTRY 4NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 13Thoracic 10Gastrointestinal 7Dermatologic 6CNS 6Breast 6Other hematologic neoplasm 4Lymphoid 4Plasma cell 3Head & Neck 2Sarcoma 1Other neoplasm 1Other 1Myeloid 1Endocrine 1

Conditions

Lymphoma, Non-Hodgkin 767Lymphoma 713Leukemia, Lymphocytic, Chronic, B-Cell 560Lymphoma, Follicular 515Lymphoma, Large B-Cell, Diffuse 440Precursor Cell Lymphoblastic Leukemia-Lymphoma 331Recurrence 317Lymphoma, B-Cell 294Neoplasms 261Lymphoma, Mantle-Cell 251Leukemia 231Multiple Myeloma 189Hodgkin Disease 179Leukemia, Myeloid, Acute 178Lymphoma, B-Cell, Marginal Zone 135Lymphoma, T-Cell, Peripheral 119Burkitt Lymphoma 105Myelodysplastic Syndromes 101Hematologic Neoplasms 100Lymphoma, T-Cell, Cutaneous 88Waldenstrom Macroglobulinemia 84Leukemia, B-Cell 79Lymphoma, T-Cell 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 65Lymphoproliferative Disorders 57Hematologic Diseases 57Melanoma 54Carcinoma, Non-Small-Cell Lung 54Breast Neoplasms 51Mycosis Fungoides 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Disease × Lymphoid × Clear all
NCT07075185 2026-04-24

inMMyCAR

Kelonia Therapeutics, Inc.

Phase 1 Recruiting
70 enrolled
LymphoidPlasma cell

Blood Protein Disorders, Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

NCT07189806 2025-09-24

MAPLE-UK

Hvivo

Recruiting
250 enrolled
LymphoidOtherThoracic

Asthma, Bronchial Spasm, Cough, Disease, Dyspnea, Inflammation, Lymphoma, Follicular

NCT05348889 2025-02-13

First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies

Chimagen Biosciences, Ltd

Phase 1/2 Terminated
7 enrolled
LymphoidOther hematologic neoplasm

Disease, Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03312205 2019-01-09

CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

Hebei Senlang Biotechnology Inc., Ltd.

Phase 1/2 Unknown
50 enrolled
LymphoidOther hematologic neoplasm

Disease, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡